Kraig Biocraft Laboratories, Inc. (KBLB)

KBLB Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-3.03	-5.56	-8.71	-5.36	-3.2
Depreciation & Amortization	0.03	0.03	0.03	0.03	0.03
Share-Based Compensation	0.23	0.23	0.24	2.85	0.68
Other Operating Activities	1.53	3.41	6.64	1.23	1.41
Operating Cash Flow	-1.24	-1.89	-1.8	-1.25	-1.09
Capital Expenditures	-0.01	-0.01	-0.1	0	-0.1
Change in Investments	-5.18	-	-0.45	-	-
Other Investing Activities	5.18	-	-	-	-
Investing Cash Flow	-0.01	-0.01	-0.55	0	-0.1
Common Stock Issued	0	0.74	0.27	0.02	1
Other Financing Activities	-0.06	2.66	3.62	1.93	0.3
Financing Cash Flow	-0.06	3.4	3.89	1.95	1.3
Net Cash Flow	-1.31	1.51	1.54	0.69	0.11
Free Cash Flow	-1.25	-1.89	-1.9	-1.25	-1.19
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.